MIM
IBB icon

Miller Investment Management’s iShares Biotechnology ETF IBB Stock Holding History

Miller Investment Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.93M Sell
35,093
-2,353
-6% -$402K 0.59% 22
2025
Q4 		$6.32M Sell
37,446
-39,221
-51% -$6.37M 0.62% 25
2025
Q3 		$11.1M Sell
76,667
-5,282
-6% -$721K 1.11% 22
2025
Q2 		$10.4M Sell
81,949
-115
-0.1% -$14.1K 1.09% 22
2025
Q1 		$10.5M Sell
82,064
-376
-0.5% -$51K 1.16% 21
2024
Q4 		$10.9M Sell
82,440
-123
-0.1% -$17.3K 1.19% 21
2024
Q3 		$12M Sell
82,563
-1,521
-2% -$220K 1.25% 21
2024
Q2 		$11.5M Sell
84,084
-5,947
-7% -$794K 1.38% 22
2024
Q1 		$12.4M Sell
90,031
-91
-0.1% -$12.4K 1.58% 20
2023
Q4 		$12.2M Buy
90,122
+86,509
+2,394% +$10.6M 1.74% 18
2023
Q3 		$442K Sell
3,613
-199
-5% -$25.3K 0.07% 77
2023
Q2 		$484K Buy
3,812
+1,670
+78% +$217K 0.07% 77
2023
Q1 		$277K Buy
+2,142
New +$280K 0.05% 85

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Miller Investment Management's IBB Position: Q1 2026 in Review

Miller Investment Management reduced its iShares Biotechnology ETF (IBB) stake by 6.3% in Q1 2026, selling an estimated $402K and leaving 35,093 shares worth $5.93M. The position accounts for 0.59% of the portfolio, ranked #22.

Miller Investment Management first reported a position in IBB in Q1 2023 and has held it in 13 quarters since. The position peaked at $12.4M in Q1 2024. 919 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Miller Investment Management held 35,093 shares of iShares Biotechnology ETF worth $5.93M as of Q1 2026.
  • Miller Investment Management sold 2,353 iShares Biotechnology ETF shares in Q1 2026, an estimated $402K.
  • iShares Biotechnology ETF made up 0.59% of Miller Investment Management's portfolio in Q1 2026, its #22 holding.
  • Miller Investment Management first reported a position in iShares Biotechnology ETF in Q1 2023 and has held it in 13 quarters since.
  • Miller Investment Management's iShares Biotechnology ETF position peaked at $12.4M in Q1 2024.
  • 919 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Miller Investment Management's 13F filing for Q1 2026, filed 8 May 2026.